Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy

被引:175
作者
Zelman, DC
Dukes, E
Brandenburg, N
Bostrom, A
Gore, M
机构
[1] Alliant Int Univ, Calif Sch Profess Psychol, San Francisco, CA 94133 USA
[2] Pfizer Inc, Outcomes Res Dept, New York, NY 10017 USA
[3] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94133 USA
[4] Avalon Hlth Solut Inc, Philadelphia, PA 19102 USA
关键词
brief pain inventory; neuropathic pain; diabetic peripheral neuropathy; pain assessment; reliability; validity; pain intensity; pain interference;
D O I
10.1016/j.pain.2005.01.028
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This study identified discrete categories of pain severity in a sample of patients with painful diabetic peripheral neuropathy (DPN), through derivation of cut-points on a 0-10 scale of pain severity (Brief Pain Inventory-DPN, BPI-DPN). Subjects were participants in a burden of illness survey (N=255). Serlin and colleagues' method establishing cut-points for cancer pain was adapted, considering all possible cut-points between 4 and 8. Optimal cut-points were those that created three pain severity categories producing maximum between-category differences on the seven BPI-DPN Interference items, using MANOVA. Cut-points of 4 and 7 optimally classified the sample for both Worst Pain and Average Pain, creating categories of mild, 0-3; moderate, 4-6; severe, 7 and higher (Hotelling's T-2 = 22.95 and 16.20 for Worst and Average Pain, P < 0.0001). Mean BPI-DPN Interference was 2.1 (SD = 2.1), 4.9 (SD = 1.9) and 7.4 (SD = 1.6) for the mild, moderate and severe pain categories. Patients in the three categories differed significantly on patient-rated outcomes (Medical Outcomes Study Short Form-12v2 Mental and Physical Component Summaries and EuroQOL utility score), and on DPN-related healthcare visits (P < 0.001). The labels 'mild, moderate and severe' Worst and Average Pain corresponded with patients' ratings of their pain using a verbal rating scale. This research shows that three categories of DPN pain severity can be identified based oil interference with daily function, and that these categories are associated with patient Outcomes and medical utilization. (c) 2005 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 25 条
[1]  
[Anonymous], 2002, The SF-12v2TM how to score version 2 of the SF-12® health survey:(with a supplement documenting version 1)
[2]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[3]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[4]  
Cleeland CS, 1991, EFFECT CANC QUALITY, P293
[5]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108
[6]  
DWORKIN R, 2002, HDB PAIN ASSESSMENT, P519
[7]   Advances in neuropathic pain - Diagnosis, mechanisms, and treatment recommendations [J].
Dworkin, RH ;
Backonja, M ;
Rowbotham, MC ;
Allen, RR ;
Argoff, CR ;
Bennett, GJ ;
Bushnell, MC ;
Farrar, JT ;
Galer, BS ;
Haythornthwaite, JA ;
Hewitt, DJ ;
Loeser, JD ;
Max, MB ;
Saltarelli, M ;
Schmader, KE ;
Stein, C ;
Thompson, D ;
Turk, DC ;
Wallace, MS ;
Watkins, LR ;
Weinstein, SM .
ARCHIVES OF NEUROLOGY, 2003, 60 (11) :1524-1534
[8]   THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY [J].
DYCK, PJ ;
KRATZ, KM ;
KARNES, JL ;
LITCHY, WJ ;
KLEIN, R ;
PACH, JM ;
WILSON, DM ;
OBRIEN, PC ;
MELTON, LJ .
NEUROLOGY, 1993, 43 (04) :817-824
[9]   Defining the clinically important difference in pain outcome measures [J].
Farrar, JT ;
Portenoy, RK ;
Berlin, JA ;
Kinman, JL ;
Strom, BL .
PAIN, 2000, 88 (03) :287-294
[10]   Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life [J].
Galer, BS ;
Gianas, A ;
Jensen, MP .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 47 (02) :123-128